Amazon wants to prevent the common cold with a vaccine

Amazon, the e-commerce giant that continues to increasingly dip its toe into the healthcare space, is reportedly working on a vaccine that could cure the common cold, according to CNBC. The work is a years-long effort with a secret name, “Project Gesundheit,” CNBC reported, citing sources familiar with the project.

Amazon has dedicated more than 100 people in its research and development group within AWS called Grand Challenge, with a small subset working on curing the common cold with the goal of developing a vaccine. A vaccine for the common cold has eluded healthcare specialists, but some experts say a treatment is possible.

While Amazon hasn’t publicly acknowledged Grand Challenge, the group is focused on solving significant challenges. And a big breakthrough would mean Amazon built its next big business from within, CNBC reported.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”